A 2014 Cochrane Systematic Review studied the effectiveness of ranibizumab and pegaptanib, on patients suffering from macular edema caused by central retinal vein occlusion.
En 2014 unha Revisión Sistemática Cochrane estudou a efectividade do ranibizumab e o pegaptanib, en pacientes que sofren edema macular causado por oclusión da vea retinal central.